Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients

Journal of Infectious Diseases

Volumn 179, Issue 2, 1999, Pages 484-488

  Humar, A ^b   St Louis, P ^b   Mazzulli, T ^b   McGeer, A ^b   Lipton, J ^b   Messner, H ^b   MacDonald, Kelly S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; VIRUS CULTURE;

ADULT; BONE MARROW TRANSPLANTATION; CYTOKINES; CYTOMEGALOVIRUS INFECTIONS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; MULTIVARIATE ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS ACTIVATION;

EID: 0033018410     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314602     Document Type: Article

References (15)

1. Sable CA, Donowitz GR. Infections in bone marrow transplant recipients. Clin Infect Dis 1994;18:273-84.
2. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986;153:478-88.
3. Döcke WD, Prösch S, Fietze E, et al. Cytomegalovirus reactivation tumour necrosis factor. Lancet 1994;343:268-9.
4. Geist LJ, Dai LY. Cytomegalovirus modulates interleukin-6 gene expression. Transplantation 1996;62:653-8.
5. Fietze E, Prösch S, Reinke P, et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994;58:675-80.
6. Stein J, Volk HD, Liebenthal C, Krüger DH, Prösch S. Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus immediate-early enhancer/promoter in immature monocytic cells. J Gen Virol 1993;74:2333-8.
7. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C cytokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 1998;177:1465-74.
8. Craigen JL, Yong KL, Jordan NJ, et al. Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 1997;92:138-45.
9. Mazzulli T, Wood S, Chua R, Walmsley S. Evaluation of the digene hybrid capture system for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus infected patients. J Clin Microbiol 1996;34:2959-62.
10. Ljungman P, Plotkin SA. Workshop on CMV disease; definitions, clinical severity scores, and new syndromes. Proceedings from the 5th International Cytomegalovirus Conference, May 21-24, 1995, Stockholm, Sweden. Scand J Infect Dis Suppl 1995;99:87-9.
11. Rowe JM, Ciobanu N, Ascensao J, et al. Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation: a report from the Eastern Cooperative Oncology Group (ECOG). Ann Intern Med 1994;120:143-58.
12. Chasty RC, Lamb WR, Gallati H, Roberts TE, Brenchley PEC, Liu Yin JA. Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1993;12:331-6.
13. Rowbottom AW, Riches PG, Downie C, Hobbs JR. Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 1993;12:635-41.
14. Remberger M, Ringden O, Markling L. TNFα levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD. Bone Marrow Transplant 1995;15:99-104.
15. Yoshida Y, Iwaki Y, Pham S, et al. Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation. Ann Thorae Surg 1993;55:89-93.